These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8012351)

  • 1. Insert size and flanking haplotype in fragile X and normal populations: possible multiple origins for the fragile X mutation.
    Macpherson JN; Bullman H; Youings SA; Jacobs PA
    Hum Mol Genet; 1994 Mar; 3(3):399-405. PubMed ID: 8012351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data on the CGG repeat at the fragile X site in the non-retarded Japanese population and family suggest the presence of a subgroup of normal alleles predisposing to mutate.
    Arinami T; Asano M; Kobayashi K; Yanagi H; Hamaguchi H
    Hum Genet; 1993 Nov; 92(5):431-6. PubMed ID: 8244331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striking founder effect for the fragile X syndrome in Finland.
    Oudet C; von Koskull H; Nordström AM; Peippo M; Mandel JL
    Eur J Hum Genet; 1993; 1(3):181-9. PubMed ID: 8044645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile X founder chromosome effects: linkage disequilibrium or microsatellite heterogeneity?
    Zhong N; Ye L; Dobkin C; Brown WT
    Am J Med Genet; 1994 Jul; 51(4):405-11. PubMed ID: 7943008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linkage disequilibrium between the fragile X mutation and two closely linked CA repeats suggests that fragile X chromosomes are derived from a small number of founder chromosomes.
    Oudet C; Mornet E; Serre JL; Thomas F; Lentes-Zengerling S; Kretz C; Deluchat C; Tejada I; Boué J; Boué A
    Am J Hum Genet; 1993 Feb; 52(2):297-304. PubMed ID: 8094266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome.
    Eichler EE; Macpherson JN; Murray A; Jacobs PA; Chakravarti A; Nelson DL
    Hum Mol Genet; 1996 Mar; 5(3):319-30. PubMed ID: 8852655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and Cyprus.
    Syrrou M; Patsalis PC; Georgiou I; Hadjimarcou MI; Constantinou-Deltas CD; Pagoulatos G
    Am J Med Genet; 1996 Jul; 64(1):234-8. PubMed ID: 8826482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fragile X syndrome in Finland: demonstration of a founder effect by analysis of microsatellite haplotypes.
    Haataja R; Väisänen ML; Li M; Ryynänen M; Leisti J
    Hum Genet; 1994 Nov; 94(5):479-83. PubMed ID: 7959680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origins of the fragile X syndrome mutation.
    Hirst MC; Knight SJ; Christodoulou Z; Grewal PK; Fryns JP; Davies KE
    J Med Genet; 1993 Aug; 30(8):647-50. PubMed ID: 8411050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FMR1 haplotype analyses among Indians: a weak founder effect and other findings.
    Sharma D; Gupta M; Thelma BK
    Hum Genet; 2003 Mar; 112(3):262-71. PubMed ID: 12596051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of FMR1 and flanking microsatellite markers in normal and fragile X chromosomes in Portugal: evidence for a "protector" haplotype.
    Peixoto A; dos Santos MR; Seruca R; Amorim A; Castedo S
    Eur J Hum Genet; 1998; 6(5):518-22. PubMed ID: 9801877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A complex mutable polymorphism located within the fragile X gene.
    Zhong N; Dobkin C; Brown WT
    Nat Genet; 1993 Nov; 5(3):248-53. PubMed ID: 8275089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles.
    Kunst CB; Warren ST
    Cell; 1994 Jun; 77(6):853-61. PubMed ID: 7911740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X founder chromosomes in Italy: a few initial events and possible explanation for their heterogeneity.
    Chiurazzi P; Genuardi M; Kozak L; Giovannucci-Uzielli ML; Bussani C; Dagna-Bricarelli F; Grasso M; Perroni L; Sebastio G; Sperandeo MP; Oostra BA; Neri G
    Am J Med Genet; 1996 Jul; 64(1):209-15. PubMed ID: 8826478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of the fragile X syndrome CGG repeat and the short-tandem-repeat and single-nucleotide-polymorphism haplotypes in an African American population.
    Crawford DC; Schwartz CE; Meadows KL; Newman JL; Taft LF; Gunter C; Brown WT; Carpenter NJ; Howard-Peebles PN; Monaghan KG; Nolin SL; Reiss AL; Feldman GL; Rohlfs EM; Warren ST; Sherman SL
    Am J Hum Genet; 2000 Feb; 66(2):480-93. PubMed ID: 10677308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong founder effect for the fragile X syndrome in Sweden.
    Malmgren H; Gustavson KH; Oudet C; Holmgren G; Pettersson U; Dahl N
    Eur J Hum Genet; 1994; 2(2):103-9. PubMed ID: 8044655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of founder chromosomes in fragile X syndrome.
    Richards RI; Holman K; Friend K; Kremer E; Hillen D; Staples A; Brown WT; Goonewardena P; Tarleton J; Schwartz C
    Nat Genet; 1992 Jul; 1(4):257-60. PubMed ID: 1302021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes.
    van den Ouweland AM; Deelen WH; Kunst CB; Uzielli ML; Nelson DL; Warren ST; Oostra BA; Halley DJ
    Hum Mol Genet; 1994 Oct; 3(10):1823-7. PubMed ID: 7849707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-examination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism in FMR1.
    Gunter C; Paradee W; Crawford DC; Meadows KA; Newman J; Kunst CB; Nelson DL; Schwartz C; Murray A; Macpherson JN; Sherman SL; Warren ST
    Hum Mol Genet; 1998 Nov; 7(12):1935-46. PubMed ID: 9811938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.